1. Home
  2. BMRA vs BRTX Comparison

BMRA vs BRTX Comparison

Compare BMRA & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.16

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.29

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRA
BRTX
Founded
1971
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.3M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
BMRA
BRTX
Price
$2.16
$0.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.6K
4.0M
Earning Date
04-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.08
EPS
N/A
N/A
Revenue
$5,311,000.00
$81,000.00
Revenue This Year
N/A
$24.64
Revenue Next Year
N/A
$287.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.19
52 Week High
$4.60
$2.04

Technical Indicators

Market Signals
Indicator
BMRA
BRTX
Relative Strength Index (RSI) 46.37 41.93
Support Level $1.87 $0.20
Resistance Level $2.23 $0.30
Average True Range (ATR) 0.13 0.04
MACD 0.02 0.03
Stochastic Oscillator 47.76 72.47

Price Performance

Historical Comparison
BMRA
BRTX

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: